[Federal Register: July 29, 2003 (Volume 68, Number 145)]
[Notices]               
[Page 44540]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29jy03-65]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Medical Devices Dispute Resolution Panel of the Medical Devices 
Advisory Committee; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The meeting of the Medical Devices Dispute Resolution Panel of 
the Medical Devices Advisory Committee scheduled for August 20, 2003, 
is cancelled based upon a decision by the sponsor, CardioGenesis Corp. 
to submit additional information for FDA review in support of their 
premarket approval application for the Axcis Percutaneous Myocardial 
Revascularization. This meeting was announced in the Federal Register 
of July 21, 2003 (68 FR 43133).

FOR FURTHER INFORMATION CONTACT: Les Weinstein, Center for Devices and 
Radiological Health (HFZ-5), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-827-7991, FAX 301-827-2565, 
lsw@cdrh.fda.gov, or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington, DC area), code 10232.

    Dated: July 23, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 03-19172 Filed 7-28-03; 8:45 am]

BILLING CODE 4160-01-S